Rheumatoid Arthritis (RA)
Pfizer Personal Empowerment Portal
Rheumatoid Arthritis
Patient-centered Tools for Education & Engagement
Pfizer is committed to helping people with rheumatoid arthritis (RA) become empowered to play an important role in managing their medical condition. What does personal empowerment mean? It is a process that may help patients work with their medical team to act on medical and lifestyle issues that they, together, define as important. Empowerment means becoming a partner with the healthcare professional (HCP) team to participate in shared decision-making on personal treatment-related issues and options.
Image of patient

The following materials―created by Pfizer Medical Affairs―provide important content for adult patients who have RA. These materials:

  • Offer insights for adult patients into the characteristics of RA and how it can be managed
  • Provide a refresher for adult patients on disease-related information that can be used to educate family members or friends about RA
  • Can help patients track their RA disease activity and functional status
  • Can help support the Treat-to-Target (T2T) approach to care based on shared decision-making and routine assessment of RA disease activity



Rheumatoid Arthritis: Disease Diagnosis and Management Materials
Patient empowerment begins with understanding how RA can be diagnosed and managed. These materials provide a helpful overview of RA, including disease characteristics and some types of therapies that may be used to manage it.
Image of brochure
Understanding Rheumatoid Arthritis Disease Activity...Above and Below the Surface

Read an overview of RA and the importance of taking your medicine as prescribed.

Image of brochure

Understanding Rheumatoid Arthritis (RA) Disease Activity…Above and Below the Surface (Instructional Video) 

This in-depth instructional video provides detailed information on RA including common signs and symptoms, the underlying causes of RA, and disease management approaches.
 

Play Video
CLOSE

Treat-to-Target (T2T) Patient Materials

Understanding T2T

Treat-to-Target (T2T) emphasizes the process of shared decision-making between patients and members of the medical team. Shared decision-making can only happen if patients are well informed about RA and their treatment options and communicate their expectations. The educational information on this site may help patients be better prepared to discuss their treatment choices, goals, and objectives with their HCPs.

Image of video
T2T Video Part 1: T2T Overview

In this 3-part video, learn about the principles and recommendations of T2T and how patients and their HCP can work together to identify T2T goals.

Play Video

CLOSE

Image of video
T2T Video Part 2: The 4 T2T Principles

In part 2, see how patients and their HCP can make treatment decisions about RA using the 4 T2T principles. Also learn about the core goals of an RA treatment plan.

Play Video

CLOSE

Image of video
T2T Video Part 3: The 10 T2T Recommendations

In part 3, find out how RA disease activity can be measured against goals that patients and their HCP set together using the 10 T2T Recommendations.

Play Video

CLOSE

image of tear sheet
T2T Tear Sheet

Read about the 4 T2T Principles and the 10 T2T Recommendations, which outline the goals of an RA treatment plan and the ways HCPs measure RA disease activity.

MDHAQ Patient Materials
image of guide cover
Patient Instruction Guide: How to Use the MDHAQ

This guide helps patients understand how to use the MDHAQ (Multi-Dimensional Health Assessment Questionnaire) to calculate their RAPID3 (Routine Assessment of Patient Index Data 3) score by answering 3 lifestyle-related questions. The guide also instructs patients on how to work with their doctor to apply this score to track their RA disease activity over time.

image of video
How to Use the MDHAQ Questionnaire (Instructional Video)a

Learn how answering 3 questions from the MDHAQ will help patients work with their doctor to calculate their RAPID3 score to measure RA disease activity.

Play Video (English version)

CLOSE

Play Video (Spanish version)

CLOSE

image of questionnaire
MDHAQ Questionnairea

This 2-page questionnaire allows patients to calculate their MDHAQ score and their RAPID3 score, which may be used to assess their level of RA disease activity. Patients can write down their scores and bring the information to their next doctor's appointment.

image of patient tracker
MDHAQ Patient Tracker

This resource lets you record your RAPID3 scores—based on questions in the MDHAQ questionnaire—in order to monitor your RA disease activity and identify important information for discussion with your healthcare professional.

RAPID3 Patient Materials
image of questionnaire
Patient Instruction Guide: How to Use the RAPID3

This guide helps patients learn how to use the RAPID3 (Routine Assessment of Patient Index Data 3) form to calculate a RAPID3 score. The RAPID3 survey converts patients' answers on how RA is affecting them into a numerical score that can be used to monitor RA disease activity over time.

image of video
How to Use the RAPID3 Questionnaire (Instructional Video)a

Explore the RAPID3 self-assessment questionnaire and how to use it to calculate the RAPID3 score. This video provides step-by-step instructions on how to complete the RAPID3 Questionnaire, as well as how to record information for discussion with healthcare professionals.

Play Video (English version)

CLOSE

Play Video (Spanish version)

CLOSE

image of questionnaire
RAPID3 Questionnairea

This self-assessment questionnaire generates information to help calculate a RAPID3 score and provides an explanation of those numerical results. Patients can write down their scores and bring the information to their next doctor's appointment.

image of patient tracker
RAPID3 Patient Tracker

This logbook enables you to record your RAPID3 scores, based on the RAPID3 questionnaire, to monitor your RA disease activity and identify important information for discussion with your healthcare professional.



aReproduction or distribution of this material is strictly prohibited without permission.
The RAPID3 system, and all copyright and trademark rights related thereto, is owned by Theodore Pincus and incorporated herein under license.